KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Supernus Pharmaceuticals (SUPN) Shares Outstanding: 2011-2023

Historic Shares Outstanding for Supernus Pharmaceuticals (SUPN) over the last 5 years, with Dec 2023 value amounting to $54.7 million.

  • Supernus Pharmaceuticals' Shares Outstanding rose 0.87% to $54.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $54.7 million, marking a year-over-year increase of 0.87%. This contributed to the annual value of $54.7 million for FY2023, which is 0.87% up from last year.
  • According to the latest figures from Q4 2023, Supernus Pharmaceuticals' Shares Outstanding is $54.7 million, which was up 0.87% from $54.3 million recorded in Q4 2022.
  • Over the past 5 years, Supernus Pharmaceuticals' Shares Outstanding peaked at $54.7 million during Q4 2023, and registered a low of $52.4 million during Q1 2019.
  • In the last 3 years, Supernus Pharmaceuticals' Shares Outstanding had a median value of $53.4 million in 2022 and averaged $53.6 million.
  • Data for Supernus Pharmaceuticals' Shares Outstanding shows a peak YoY increased of 1.87% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Shares Outstanding stood at $52.5 million in 2019, then increased by 0.64% to $52.9 million in 2020, then climbed by 0.73% to $53.3 million in 2021, then rose by 1.87% to $54.3 million in 2022, then grew by 0.87% to $54.7 million in 2023.
  • Its Shares Outstanding stands at $54.7 million for Q4 2023, versus $54.3 million for Q4 2022 and $54.1 million for Q3 2022.